中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2015年
15期
40-41
,共2页
中药%五苓散%急性脑梗死%药理作用
中藥%五苓散%急性腦梗死%藥理作用
중약%오령산%급성뇌경사%약리작용
Traditional Chinese medicine%Wulingsan%Acute cerebral infarction%Pharmacological action
目的：总结中药五苓散的临床药理作用，探讨中药五苓散治疗急性脑梗死的临床疗效。方法回顾性分析100例急性脑梗死患者的临床资料，按治疗方式的不同分为2组，各50例。对照组接受西医常规保守治疗，观察组接受西医常规保守治疗+中药五苓散。观察对比指标包括：清醒时间及清醒率；格拉斯哥预后评分（GOS）及发症发生率。结果观察组50例患者的平均清醒时间是（3.74±0.48）d，随访1个月后，观察组患者的清醒率达49例（98%），GCS评分（9.74±0.35）分；对照组50例患者的平均清醒时间是（6.13±0.79）d，随访1个月后，观察组患者的清醒率达40例（80%），GCS评分（7.58±0.49）分。观察组患者的平均清醒时间短于对照组，1个月清醒率显著大于对照组，GCS评分高于对照组，均有统计学差异（P<0.05）。随访1个月后，观察组患者的并发症发生率为10%，显著低于对照组患者36%，均有统计学差异（P<0.05）。结论采用中药五苓散治疗急性脑梗死，临床疗效显著，值得临床推广。
目的：總結中藥五苓散的臨床藥理作用，探討中藥五苓散治療急性腦梗死的臨床療效。方法迴顧性分析100例急性腦梗死患者的臨床資料，按治療方式的不同分為2組，各50例。對照組接受西醫常規保守治療，觀察組接受西醫常規保守治療+中藥五苓散。觀察對比指標包括：清醒時間及清醒率；格拉斯哥預後評分（GOS）及髮癥髮生率。結果觀察組50例患者的平均清醒時間是（3.74±0.48）d，隨訪1箇月後，觀察組患者的清醒率達49例（98%），GCS評分（9.74±0.35）分；對照組50例患者的平均清醒時間是（6.13±0.79）d，隨訪1箇月後，觀察組患者的清醒率達40例（80%），GCS評分（7.58±0.49）分。觀察組患者的平均清醒時間短于對照組，1箇月清醒率顯著大于對照組，GCS評分高于對照組，均有統計學差異（P<0.05）。隨訪1箇月後，觀察組患者的併髮癥髮生率為10%，顯著低于對照組患者36%，均有統計學差異（P<0.05）。結論採用中藥五苓散治療急性腦梗死，臨床療效顯著，值得臨床推廣。
목적：총결중약오령산적림상약리작용，탐토중약오령산치료급성뇌경사적림상료효。방법회고성분석100례급성뇌경사환자적림상자료，안치료방식적불동분위2조，각50례。대조조접수서의상규보수치료，관찰조접수서의상규보수치료+중약오령산。관찰대비지표포괄：청성시간급청성솔；격랍사가예후평분（GOS）급발증발생솔。결과관찰조50례환자적평균청성시간시（3.74±0.48）d，수방1개월후，관찰조환자적청성솔체49례（98%），GCS평분（9.74±0.35）분；대조조50례환자적평균청성시간시（6.13±0.79）d，수방1개월후，관찰조환자적청성솔체40례（80%），GCS평분（7.58±0.49）분。관찰조환자적평균청성시간단우대조조，1개월청성솔현저대우대조조，GCS평분고우대조조，균유통계학차이（P<0.05）。수방1개월후，관찰조환자적병발증발생솔위10%，현저저우대조조환자36%，균유통계학차이（P<0.05）。결론채용중약오령산치료급성뇌경사，림상료효현저，치득림상추엄。
Objective?To?summarize?the?clinical?pharmacological?effects?of?traditional?Chinese?medicine?wulingsan?,?to?study?the?clinical?curative?effect?of?Chinese?medicine?wulingsan?treating?acute?cerebral?infarction.?Methods?The?clinical?data?of?100?cases?of?patients?with?acute?cerebral?infarction?were?given?retrospective?analysis?,?according?to?the?different?treatment?methods?they?were?divided?into?2?groups,?50?cases?in?each.?The?control?group?received?routine?western?medicine?conservative?treatment,?the?observation?group?received?routine?western?medicine?conservative?treatment?plus?traditional?Chinese?medicine?Poria?five?powder.?Comparative?observation?of?indicators?include:?awake?time?and?wakefulness?rate;?Glasgow?outcome?score?(GOS)?and?the?incidence?of?complications.?Results?The?average?time?of?observation?group?of?50?patients?was?(3.74±0.48)d,?after?1?months?of?follow-up,?the?rate?of?patients?was?observed?in?49?cases?(98%),?GCS?score?(9.74±0.35)?average?time;?control?group?of?50?patients?was?(6.13±0.79)d,?after?1?months?of?follow-up,?to?observe?the?awake?rate?group?patients?of?40?cases?(80%),?GCS?score?(7.58±0.49).?Patients?in?the?observation?group?the?average?time?was?shorter?than?the?control?group,?1?months?sober?rate?was?significantly?greater?than?that?of?the?control?group,?GCS?was?higher?than?that?of?the?control?group,?there?were?significant?differences?between?the?(P<0.05).?After?1?months?of?follow-up,?patients?in?the?observation?group?the?incidence?of?complications?was?10%,?significantly?lower?than?the?control?group?of?36%?patients,?were?statistically?significant?difference?(P<0.05).?Conclusion?The?clinical?curative?effect?of?Chinese?medicine?wulingsan?in?treatment?of?acute?cerebral?infarction?is?distinct,?,?it?is?worth?the?clinical?promotion.
